Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Other Working Capital Changes (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Other Working Capital Changes readings, the most recent being -$16.9 million for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 51.77% to -$16.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.8 million, a 86.22% increase, with the full-year FY2025 number at -$4.8 million, up 86.22% from a year prior.
  • Other Working Capital Changes hit -$16.9 million in Q4 2025 for Tandem Diabetes Care, down from $7.3 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $10.6 million in Q4 2023 to a low of -$35.1 million in Q4 2024.
  • Median Other Working Capital Changes over the past 5 years was $52500.0 (2021), compared with a mean of -$1.4 million.
  • Biggest five-year swings in Other Working Capital Changes: crashed 769.4% in 2022 and later surged 25034.48% in 2025.
  • Tandem Diabetes Care's Other Working Capital Changes stood at $1.3 million in 2021, then grew by 12.5% to $1.4 million in 2022, then soared by 643.74% to $10.6 million in 2023, then tumbled by 431.88% to -$35.1 million in 2024, then surged by 51.77% to -$16.9 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$16.9 million (Q4 2025), $7.3 million (Q3 2025), and $6.4 million (Q2 2025) per Business Quant data.